Global Biosimilar Drug Market Professional Survey Report 2018

Publisher Name :
Date: 08-Mar-2018
No. of pages: 100
Inquire Before Buying

This report studies Biosimilar Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

- CP Guojian Pharma

- Biotech Pharma

- Celgen Pharma

- Henlius

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Injection

- Tablets

- Others

By Application, the market can be split into

- Ankylosing Spondylitis

- Tumor

- Rheumatoid Arthrtis

- Cardiovascular

By Regions, this report covers (we can add the regions/countries as you want)

- North America

- China

- Europe

- Southeast Asia

- Japan

- India

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Biosimilar Drug Market Professional Survey Report 2018

Table of Contents
Global Biosimilar Drug Market Professional Survey Report 2018
1 Industry Overview of Biosimilar Drug
1.1 Definition and Specifications of Biosimilar Drug
1.1.1 Definition of Biosimilar Drug
1.1.2 Specifications of Biosimilar Drug
1.2 Classification of Biosimilar Drug
1.2.1 Injection
1.2.2 Tablets
1.2.3 Others
1.3 Applications of Biosimilar Drug
1.3.1 Ankylosing Spondylitis
1.3.2 Tumor
1.3.3 Rheumatoid Arthrtis
1.3.4 Cardiovascular
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Biosimilar Drug
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Biosimilar Drug
2.3 Manufacturing Process Analysis of Biosimilar Drug
2.4 Industry Chain Structure of Biosimilar Drug
3 Technical Data and Manufacturing Plants Analysis of Biosimilar Drug
3.1 Capacity and Commercial Production Date of Global Biosimilar Drug Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Biosimilar Drug Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Biosimilar Drug Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Biosimilar Drug Major Manufacturers in 2017
4 Global Biosimilar Drug Overall Market Overview
4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2013-2018E Global Biosimilar Drug Capacity and Growth Rate Analysis
4.2.2 2017 Biosimilar Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2013-2018E Global Biosimilar Drug Sales and Growth Rate Analysis
4.3.2 2017 Biosimilar Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2013-2018E Global Biosimilar Drug Sales Price
4.4.2 2017 Biosimilar Drug Sales Price Analysis (Company Segment)
5 Biosimilar Drug Regional Market Analysis
5.1 North America Biosimilar Drug Market Analysis
5.1.1 North America Biosimilar Drug Market Overview
5.1.2 North America 2013-2018E Biosimilar Drug Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2013-2018E Biosimilar Drug Sales Price Analysis
5.1.4 North America 2017 Biosimilar Drug Market Share Analysis
5.2 China Biosimilar Drug Market Analysis
5.2.1 China Biosimilar Drug Market Overview
5.2.2 China 2013-2018E Biosimilar Drug Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2013-2018E Biosimilar Drug Sales Price Analysis
5.2.4 China 2017 Biosimilar Drug Market Share Analysis
5.3 Europe Biosimilar Drug Market Analysis
5.3.1 Europe Biosimilar Drug Market Overview
5.3.2 Europe 2013-2018E Biosimilar Drug Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2013-2018E Biosimilar Drug Sales Price Analysis
5.3.4 Europe 2017 Biosimilar Drug Market Share Analysis
5.4 Southeast Asia Biosimilar Drug Market Analysis
5.4.1 Southeast Asia Biosimilar Drug Market Overview
5.4.2 Southeast Asia 2013-2018E Biosimilar Drug Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2013-2018E Biosimilar Drug Sales Price Analysis
5.4.4 Southeast Asia 2017 Biosimilar Drug Market Share Analysis
5.5 Japan Biosimilar Drug Market Analysis
5.5.1 Japan Biosimilar Drug Market Overview
5.5.2 Japan 2013-2018E Biosimilar Drug Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2013-2018E Biosimilar Drug Sales Price Analysis
5.5.4 Japan 2017 Biosimilar Drug Market Share Analysis
5.6 India Biosimilar Drug Market Analysis
5.6.1 India Biosimilar Drug Market Overview
5.6.2 India 2013-2018E Biosimilar Drug Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2013-2018E Biosimilar Drug Sales Price Analysis
5.6.4 India 2017 Biosimilar Drug Market Share Analysis
6 Global 2013-2018E Biosimilar Drug Segment Market Analysis (by Type)
6.1 Global 2013-2018E Biosimilar Drug Sales by Type
6.2 Different Types of Biosimilar Drug Product Interview Price Analysis
6.3 Different Types of Biosimilar Drug Product Driving Factors Analysis
6.3.1 Injection of Biosimilar Drug Growth Driving Factor Analysis
6.3.2 Tablets of Biosimilar Drug Growth Driving Factor Analysis
6.3.3 Others of Biosimilar Drug Growth Driving Factor Analysis
7 Global 2013-2018E Biosimilar Drug Segment Market Analysis (by Application)
7.1 Global 2013-2018E Biosimilar Drug Consumption by Application
7.2 Different Application of Biosimilar Drug Product Interview Price Analysis
7.3 Different Application of Biosimilar Drug Product Driving Factors Analysis
7.3.1 Ankylosing Spondylitis of Biosimilar Drug Growth Driving Factor Analysis
7.3.2 Tumor of Biosimilar Drug Growth Driving Factor Analysis
7.3.3 Rheumatoid Arthrtis of Biosimilar Drug Growth Driving Factor Analysis
7.3.4 Cardiovascular of Biosimilar Drug Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Biosimilar Drug
8.1 CP Guojian Pharma
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 CP Guojian Pharma 2017 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 CP Guojian Pharma 2017 Biosimilar Drug Business Region Distribution Analysis
8.2 Biotech Pharma
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Biotech Pharma 2017 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Biotech Pharma 2017 Biosimilar Drug Business Region Distribution Analysis
8.3 Celgen Pharma
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Celgen Pharma 2017 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Celgen Pharma 2017 Biosimilar Drug Business Region Distribution Analysis
8.4 Henlius
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Henlius 2017 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Henlius 2017 Biosimilar Drug Business Region Distribution Analysis
9 Development Trend of Analysis of Biosimilar Drug Market
9.1 Global Biosimilar Drug Market Trend Analysis
9.1.1 Global 2018-2025 Biosimilar Drug Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Biosimilar Drug Sales Price Forecast
9.2 Biosimilar Drug Regional Market Trend
9.2.1 North America 2018-2025 Biosimilar Drug Consumption Forecast
9.2.2 China 2018-2025 Biosimilar Drug Consumption Forecast
9.2.3 Europe 2018-2025 Biosimilar Drug Consumption Forecast
9.2.4 Southeast Asia 2018-2025 Biosimilar Drug Consumption Forecast
9.2.5 Japan 2018-2025 Biosimilar Drug Consumption Forecast
9.2.6 India 2018-2025 Biosimilar Drug Consumption Forecast
9.3 Biosimilar Drug Market Trend (Product Type)
9.4 Biosimilar Drug Market Trend (Application)
10 Biosimilar Drug Marketing Type Analysis
10.1 Biosimilar Drug Regional Marketing Type Analysis
10.2 Biosimilar Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Biosimilar Drug by Region
10.4 Biosimilar Drug Supply Chain Analysis
11 Consumers Analysis of Biosimilar Drug
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Biosimilar Drug Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Biosimilar Drug
Table Product Specifications of Biosimilar Drug
Table Classification of Biosimilar Drug
Figure Global Production Market Share of Biosimilar Drug by Type in 2017
Figure Injection Picture
Table Major Manufacturers of Injection
Figure Tablets Picture
Table Major Manufacturers of Tablets
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Biosimilar Drug
Figure Global Consumption Volume Market Share of Biosimilar Drug by Application in 2017
Figure Ankylosing Spondylitis Examples
Table Major Consumers in Ankylosing Spondylitis
Figure Tumor Examples
Table Major Consumers in Tumor
Figure Rheumatoid Arthrtis Examples
Table Major Consumers in Rheumatoid Arthrtis
Figure Cardiovascular Examples
Table Major Consumers in Cardiovascular
Figure Market Share of Biosimilar Drug by Regions
Figure North America Biosimilar Drug Market Size (Million USD) (2013-2025)
Figure China Biosimilar Drug Market Size (Million USD) (2013-2025)
Figure Europe Biosimilar Drug Market Size (Million USD) (2013-2025)
Figure Southeast Asia Biosimilar Drug Market Size (Million USD) (2013-2025)
Figure Japan Biosimilar Drug Market Size (Million USD) (2013-2025)
Figure India Biosimilar Drug Market Size (Million USD) (2013-2025)
Table Biosimilar Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Biosimilar Drug in 2017
Figure Manufacturing Process Analysis of Biosimilar Drug
Figure Industry Chain Structure of Biosimilar Drug
Table Capacity and Commercial Production Date of Global Biosimilar Drug Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Biosimilar Drug Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Biosimilar Drug Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Biosimilar Drug Major Manufacturers in 2017
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Biosimilar Drug 2013-2018E
Figure Global 2013-2018E Biosimilar Drug Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Biosimilar Drug Market Size (Value) and Growth Rate
Table 2013-2018E Global Biosimilar Drug Capacity and Growth Rate
Table 2017 Global Biosimilar Drug Capacity (K MT) List (Company Segment)
Table 2013-2018E Global Biosimilar Drug Sales (K MT) and Growth Rate
Table 2017 Global Biosimilar Drug Sales (K MT) List (Company Segment)
Table 2013-2018E Global Biosimilar Drug Sales Price (USD/MT)
Table 2017 Global Biosimilar Drug Sales Price (USD/MT) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K MT) of Biosimilar Drug 2013-2018E
Figure North America 2013-2018E Biosimilar Drug Sales Price (USD/MT)
Figure North America 2017 Biosimilar Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K MT) of Biosimilar Drug 2013-2018E
Figure China 2013-2018E Biosimilar Drug Sales Price (USD/MT)
Figure China 2017 Biosimilar Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K MT) of Biosimilar Drug 2013-2018E
Figure Europe 2013-2018E Biosimilar Drug Sales Price (USD/MT)
Figure Europe 2017 Biosimilar Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K MT) of Biosimilar Drug 2013-2018E
Figure Southeast Asia 2013-2018E Biosimilar Drug Sales Price (USD/MT)
Figure Southeast Asia 2017 Biosimilar Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K MT) of Biosimilar Drug 2013-2018E
Figure Japan 2013-2018E Biosimilar Drug Sales Price (USD/MT)
Figure Japan 2017 Biosimilar Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K MT) of Biosimilar Drug 2013-2018E
Figure India 2013-2018E Biosimilar Drug Sales Price (USD/MT)
Figure India 2017 Biosimilar Drug Sales Market Share
Table Global 2013-2018E Biosimilar Drug Sales (K MT) by Type
Table Different Types Biosimilar Drug Product Interview Price
Table Global 2013-2018E Biosimilar Drug Sales (K MT) by Application
Table Different Application Biosimilar Drug Product Interview Price
Table CP Guojian Pharma Information List
Table Product A Overview
Table Product B Overview
Table 2017 CP Guojian Pharma Biosimilar Drug Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 CP Guojian Pharma Biosimilar Drug Business Region Distribution
Table Biotech Pharma Information List
Table Product A Overview
Table Product B Overview
Table 2017 Biotech Pharma Biosimilar Drug Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Biotech Pharma Biosimilar Drug Business Region Distribution
Table Celgen Pharma Information List
Table Product A Overview
Table Product B Overview
Table 2015 Celgen Pharma Biosimilar Drug Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Celgen Pharma Biosimilar Drug Business Region Distribution
Table Henlius Information List
Table Product A Overview
Table Product B Overview
Table 2017 Henlius Biosimilar Drug Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Henlius Biosimilar Drug Business Region Distribution
Figure Global 2018-2025 Biosimilar Drug Market Size (K MT) and Growth Rate Forecast
Figure Global 2018-2025 Biosimilar Drug Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Biosimilar Drug Sales Price (USD/MT) Forecast
Figure North America 2018-2025 Biosimilar Drug Consumption Volume (K MT) and Growth Rate Forecast
Figure China 2018-2025 Biosimilar Drug Consumption Volume (K MT) and Growth Rate Forecast
Figure Europe 2018-2025 Biosimilar Drug Consumption Volume (K MT) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Biosimilar Drug Consumption Volume (K MT) and Growth Rate Forecast
Figure Japan 2018-2025 Biosimilar Drug Consumption Volume (K MT) and Growth Rate Forecast
Figure India 2018-2025 Biosimilar Drug Consumption Volume (K MT) and Growth Rate Forecast
Table Global Sales Volume (K MT) of Biosimilar Drug by Type 2018-2025
Table Global Consumption Volume (K MT) of Biosimilar Drug by Application 2018-2025
Table Traders or Distributors with Contact Information of Biosimilar Drug by Region
  • Global Biosimilar Drug Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 10-Jun-2018        Price: US 3480 Onwards        Pages: 133
    Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine. Scope of the Report: This report focuses on the Biosimilar Drug in global market, especial......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Biosimilar Drug Market 2018, Forecast to 2023
    Published: 10-Jun-2018        Price: US 4880 Onwards        Pages: 132
    Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine. Scope of the Report: This report focuses on the Biosimilar Drug in global market, especial......
  • Global Biologics and Biosimilars Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 09-Jun-2018        Price: US 3480 Onwards        Pages: 154
    A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. Scope of the Report: This report focuses on the Biologics and Biosimilars in global market, espe......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Biologics and Biosimilars Market 2018, Forecast to 2023
    Published: 09-Jun-2018        Price: US 4880 Onwards        Pages: 150
    A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. Scope of the Report: This report focuses on the Biologics and Biosimilars in global market, espe......
  • Global and China Adalimumab Biosimilar Market Research by Company, Type & Application 2013-2025
    Published: 25-May-2018        Price: US 2000 Onwards        Pages: 78
    Summary Market Segment as follows: By Type - Tablet - Oral Solution By Application - Hospital Pharmacy - Retail Pharmacy - Online Pharmacy By Company - AET BioTech - Amgen - Boehringer Ingelheim - Coherus Biosciences - Fujifilm Kyowa Kirin Biologics - LG Life Sciences/Mochida Pharmaceutical - Momenta Pharmaceuticals - Oncobiologics - Pfize......
  • United States Biosimilar Monoclonal Antibodies Market Report 2018
    Published: 23-May-2018        Price: US 3800 Onwards        Pages: 105
    In this report, the United States Biosimilar Monoclonal Antibodies market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share an......
  • Global Biosimilar Monoclonal Antibodies Market Research Report 2018
    Published: 18-May-2018        Price: US 2900 Onwards        Pages: 110
    This report studies the global Biosimilar Monoclonal Antibodies market status and forecast, categorizes the global Biosimilar Monoclonal Antibodies market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. In 2017, the global Biosimilar Monoclonal Antibodies market size was xx million US$ and it is expected to reach xx million US$ by the end of ......
  • Global Oncology Biosimilars Market Data Survey Report 2025
    Published: 22-Apr-2018        Price: US 1500 Onwards        Pages: 80
    Summary The global Oncology Biosimilars market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Major Application Major Type Key manufacturers are included based on manufacturing sites, capacity......
  • Global and United States Biologics and Biosimilars Market Research by Company, Type & Application 2013-2025
    Published: 20-Apr-2018        Price: US 2000 Onwards        Pages: 120
    Summary A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product t......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs